Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
2.470
+0.290 (13.30%)
At close: Nov 22, 2024, 4:00 PM
2.427
-0.043 (-1.76%)
After-hours: Nov 22, 2024, 6:54 PM EST
Taysha Gene Therapies Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$6.63
Upside
+168.42%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $6 → $8 | Strong Buy | Maintains | $6 → $8 | +223.89% | Nov 15, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +183.40% | Nov 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +142.91% | Nov 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +183.40% | Nov 14, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +102.43% | Nov 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +183.40% | Nov 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +142.91% | Nov 12, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +142.91% | Aug 14, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +183.40% | Aug 13, 2024 |
| Needham | Needham | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +142.91% | Aug 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +183.40% | Jul 26, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +183.40% | Jul 23, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $7 | Buy | Maintains | $9 → $7 | +183.40% | Jul 1, 2024 |
| BMO Capital | BMO Capital | Buy Initiates $5 | Buy | Initiates | $5 | +102.43% | Jun 27, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +102.43% | Jun 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +183.40% | Jun 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.